Background: Community-acquired pneumonia (CAP) is one of the significant global issues of morbidity and mortality. Despite the far more
technological advances in the field of microbial diagnosis, the cause still remains unclear, and the treatment is usually empirical which is commonly
based on the clinical and epidemiological features.